Cargando…

Clinical predictors of survival in real world practice in stage IV melanoma

BACKGROUND AND AIM: While studies continually identify new clinical prognostic factors in stage IV melanoma, the introduction of targeted and immunotherapies have revolutionised the prognosis of advanced melanoma since 2011. The study aims to investigate the prognostic significance of past and newly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Hsien‐Pang, Archer, Christine, Yip, Desmond, Peters, Geoffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939985/ https://www.ncbi.nlm.nih.gov/pubmed/36161287 http://dx.doi.org/10.1002/cnr2.1691

Ejemplares similares

Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma
por: Rantala, Elina S., et al.
Publicado: (2021)

Real-world treatment practice in patients with advanced melanoma
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma—A Real World Single-Center Analysis
por: Hoffmann, Michèle, et al.
Publicado: (2022)

Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
por: Jain, Ankit, et al.
Publicado: (2021)

Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival
por: Lee, Ian, et al.
Publicado: (2012)

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
por: Aoude, Lauren G., et al.
Publicado: (2020)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2021)

Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
por: Randhawa, Manreet, et al.
Publicado: (2019)

Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
por: Brown, J E, et al.
Publicado: (2000)

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
por: Mandalá, Mario, et al.
Publicado: (2021)

Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
por: Jang, Sekwon, et al.
Publicado: (2020)

Surgery on primary tumor shows survival benefit in selected stage IV colon cancer patients: A real-world study based on SEER database
por: Xu, Jing, et al.
Publicado: (2020)

Patients presenting with stage IV uveal melanoma: Lessons learned
por: Garg, Gaurav, et al.
Publicado: (2022)

The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival
por: Ogata, Dai, et al.
Publicado: (2020)

Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients
por: Eisendle, Klaus, et al.
Publicado: (2020)

Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non–small cell lung cancer
por: West, Howard, et al.
Publicado: (2023)

Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
por: Jang, Sekwon, et al.
Publicado: (2020)

Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
por: Sun, Meiling, et al.
Publicado: (2022)

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
por: Ariyasu, Ryo, et al.
Publicado: (2023)

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study
por: Dawe, David E., et al.
Publicado: (2023)

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma
por: Orlow, Irene, et al.
Publicado: (2023)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Continuing and new roles for surgery in the management of patients with stage IV melanoma
por: Friedman, Erica B, et al.
Publicado: (2018)

Patients presenting with metastases: stage IV uveal melanoma, an international study
por: Garg, Gaurav, et al.
Publicado: (2022)

Delivering and managing real world network security
por: Moses, Robin, et al.
Publicado: (2006)

Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer
por: Thronicke, Anja, et al.
Publicado: (2020)

Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer—A population study
por: Wang, Christine, et al.
Publicado: (2023)

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
por: Mohr, Peter, et al.
Publicado: (2022)

Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma
por: Han, Dale, et al.
Publicado: (2015)

Real-world evidence for option value in metastatic melanoma
por: Wong, William B, et al.
Publicado: (2021)

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
por: Schad, Friedemann, et al.
Publicado: (2018)

Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR
por: Giunta, Emilio Francesco, et al.
Publicado: (2022)

Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020)

A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022)

A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations
por: Sun, Wei, et al.
Publicado: (2023)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_9nhtdcbrktfgbs1b92bvbo56ls